- Home
- GEL vs GLPG Comparison
GEL vs GLPG Comparison
Compare GEL & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GEL | GLPG |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | Belgium |
| Employees | N/A | 452 |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | GEL | GLPG |
|---|---|---|
| Price | $15.63 | $27.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $19.50 | ★ $36.50 |
| AVG Volume (30 Days) | 247.5K | ★ 263.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.19% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,912,770,000.00 | N/A |
| Revenue This Year | $12.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 43.60 | N/A |
| 52 Week Low | $14.55 | $26.62 |
| 52 Week High | $18.64 | $37.78 |
Technical Indicators
Market Signals| Indicator | GEL | GLPG |
|---|---|---|
| Relative Strength Index (RSI) | 44.10 | 36.53 |
| Support Level | $14.92 | N/A |
| Resistance Level | $16.44 | $34.04 |
| Average True Range (ATR) | 0.46 | 0.56 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 44.17 | 25.33 |
Price Performance
Historical ComparisonAbout GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, and it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.